Understanding Melasma: A Comprehensive Overview of the Skin Condition
-
By
-
Karishma Daftary
-
Roopal V. Kundu
-
September 1, 2026
Clinical Report: Understanding Melasma: A Comprehensive Overview
Overview
Melasma is a common skin condition characterized by dark facial patches, primarily affecting women of reproductive age. It is not life-threatening.
Background
Melasma affects approximately 1 in 100 individuals, with higher prevalence among those of African, Asian, Hispanic, and Middle Eastern descent. The condition is often triggered by UV exposure, hormonal changes, and genetic predisposition.
Data Highlights
No numerical or trial data provided in the source material.
Key Findings
- Melasma is characterized by symmetric dark patches on sun-exposed facial areas.
- Daily use of broad-spectrum sunscreen with SPF 30 or higher is essential for management.
- Topical treatments often include agents that lighten dark patches and even skin tone.
- Oral tranexamic acid may be considered for more severe cases of melasma.
- Procedures like chemical peels and laser treatments should be performed by board-certified dermatologists.
Clinical Implications
Clinicians should emphasize sun protection and consider topical treatments as first-line options for melasma.
Conclusion
Melasma is a chronic condition that may require ongoing management.
Related Resources & Content
- American Academy of Dermatology, Melasma overview webpage
- Frontiers in Medicine — Correction: Beyond the boundaries of pigmentation and inflammation: understanding the mechanistic basis of melasma–rosacea comorbidity
- Frontiers in Medicine — Clinical and dermoscopic analysis of 32 cases of acquired facial hyperpigmented macules
- Global consensus on the management of melanin hyperpigmentation disorders - PMC
- Comparative efficacy and safety of tranexamic acid for melasma by different administration methods: A systematic review and network meta‐analysis
- Frontiers in Medicine — Ultraviolet radiation as a double-edged regulator of melanocyte function in vitiligo therapy and melanoma carcinogenesis
- the asco post — Experts Publish Consensus Statement on Classification System for Pathology and Diagnosis of Melanocytic Lesions
- DermNet
- Global consensus on the management of melanin hyperpigmentation disorders - PMC
- Comparative efficacy and safety of tranexamic acid for melasma by different administration methods: A systematic review and network meta‐analysis - Liang - 2024 - Journal of Cosmetic Dermatology - Wiley Online Library
- Checking your browser - reCAPTCHA
Based on findings from:
Melasma
Karishma Daftary, Roopal V. Kundu. Jama Dermatology, 2026.
https://jamanetwork.com/journals/jamadermatology/fullarticle/2851487
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
